Physician profile
Steven Sameh Dalati
NPI 1023276748
$504.21
in general payments reported to CMS, 2019-2025
12 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.35 · 2021: $93.94 · 2024: $87.46 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $120.61 | 2021-2024 | |
| Organon LLC | $67.86 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $65.33 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $62.79 | 2025 | Aptima, Thinprep 2000 Processor |
| Dexcom, INC. | $47.33 | 2025 | Dexcom G6 Transmitter |
| Mayne Pharma Commercial LLC | $45.80 | 2025 | |
| Optumhealth Care Solutions, LLC | $21.76 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Acella Pharmaceuticals, LLC | $18.31 | 2025 | NP Thyroid 60 |
| Coopersurgical, INC. | $14.52 | 2024 | Paragard T 380a |
| Shield Therapeutics INC | $13.73 | 2025 | |
| Avion Pharmaceuticals | $13.35 | 2019 | |
| Meditrina | $12.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dalati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.